Aggrecan Glycoforms Contribute to the Molecular Heterogeneity of Perineuronal Nets
Open accessAbstract
The perineuronal net forms the extracellular matrix of many neurons in the CNS, surrounding neuron cell bodies and proximal dendrites in a mesh-like structure with open "holes" at the sites of synaptic contacts. The perineuronal net is first detected late in development, approximately coincident with the transformation of the CNS from an environment conducive to neuronal growth and motility to one that is restrictive, suggesting a role for the perineuronal net in this developmental transition. Perineuronal nets show a great degree of molecular heterogeneity. Using monoclonal antibodies Cat-301, Cat-315, and Cat-316, we have shown previously that although all antibodies recognize chondroitin sulfate proteoglycans of similar sizes, each antibody recognizes perineuronal nets on distinct but overlapping sets of neurons in the adult cat CNS. An understanding of the heterogeneity demonstrated by these antibodies is critical to understanding the organization and function of perineuronal nets. Using aggrecan knock-out mice (cmd), we have now determined that all three antibodies recognize aggrecan. Chemical and enzymatic deglycosylation show that the differences revealed by the three antibodies arise from differential glycosylation of aggrecan. We further demonstrate that aggrecan mRNA is expressed relatively late in development and that neurons themselves are likely the predominant cellular sites of aggrecan expression. This work indicates that neurons can directly regulate the composition of their extracellular matrix by regulated synthesis and differential glycosylation of aggrecan in a cell type-specific manner. These results have important implications for the role of regulated microheterogeneity of glycosylation in the CNS.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ACAN+ PNNs remain intact in 9m-PS19 mice, confirmed after staining with a second antibody against aggrecan, Cat-315 (p=0.75).
“The finding that PNN core proteins remain intact in 9m-PS19 mice was confirmed after staining with a second antibody against aggrecan, Cat-315 (p=0.75) (Supplemental Fig. 1) (Matthews et al. 2002)”
From Perineuronal net deglycosylation associates with tauopathy‐induced gliosis and neurodegeneration (2024) · cites this paper as Matthews et al. 2002
The content of aggrecan in ACAN+/− perineuronal nets is reduced below a critical level not sufficient to exert neuroprotective effects.
“Most likely, the content of aggrecan in these PNs is reduced below a critical level, which is not sufficient to exert the neuroprotective effects.44”
From Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress (2014) · cites this paper as [44]
The cat-301 antibody labels a distinct glycosylated form of the aggrecan core protein, whereas other glycosylated forms may be only partially recognized.
“This antibody labels a distinct glycosylated form of the aggrecan core protein, whereas other glycosylated forms may be only partially recognized.56, 75”
From Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala (2015) · cites this paper as [56]
Studies comparing PNNs detected with lectins or specific antibodies indicate substantial levels of molecular heterogeneity.
“Studies comparing PNNs detected with lectins or specific antibodies indicate substantial levels of molecular heterogeneity (Matthews et al., 2002; Irvine and Kwok, 2018), highlighting the need for better approaches which address PNN heterogeneity (Irvine and Kwok, 2018).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Matthews et al., 2002
Aggrecan is known as the predominant CSPG in PNs, occurring in several isoforms with differential distribution as shown for the human cerebral cortex.
“aggrecan known as predominant CSPG in PNs occurring in several isoforms (Matthews et al., 2002; Morawski et al., 2012a) with differential distribution as shown for the human cerebral cortex (Virgintino et al., 2009).”
From Damaged Neocortical Perineuronal Nets Due to Experimental Focal Cerebral Ischemia in Mice, Rats and Sheep (2017) · cites this paper as Matthews et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 43 · Cited by 341
- Authors
- Matthews, R. T., Kelly, G. M., Zerillo, C. A., Gray, G., Tiemeyer, M., & Hockfield, S.
- Affiliations
- Yale University (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-09-01
- Volume
- 22
- Issue
- 17
- Pages
- 7536-7547
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6757962
- OpenAlex
- W1883330555
- Cited by
- 341
- References
- 43
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 17 · 2021: 17 · 2020: 21 · 2019: 13 · 2018: 26 · 2017: 22 · 2016: 9 · 2015: 13 · 2014: 14 · 2013: 14 · 2012: 16
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (F32EY006511, EY 06511)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- perineuronal nets, aggrecan, glycosylation, chondroitin sulfate proteoglycans, extracellular matrix, monoclonal antibodies, central nervous system development, glycoforms, cell type-specific gene expression
- MeSH terms
- Animals, Antibodies, Antibody Specificity, Epitopes, Cerebral Cortex, Chondroitin Sulfates, Extracellular Matrix, Glycosylation, Neurons, Oligosaccharides, Proteoglycans, RNA, Messenger, Spinal Cord, Synapses, Extracellular Matrix Proteins, Alternative Splicing, Lectins, C-Type, Rats, Aggrecans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review